ADT1013-Adebrelimab Biosimilar (B7-H1/PD-L1/CD274)-Research Biosimilar Antibody
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1013 |
Product Name |
ADT1013-Adebrelimab Biosimilar (B7-H1/PD-L1/CD274)-Research Biosimilar Antibody |
|
Alternate Names Recombinant Anti-PDL1 antibody, PDL1 antibody, CD274 antibody, cd274 monoclonal antibody, B7H1 antibody, B7H1 monoclonal antibody, PDL1 blocking antibody, PDL1 blocking antibodies, anti-PDL1 recombinant antibody, PDL1 recombinant antibody, B7H1 recombinant antibody |
|
Clonity |
Monoclonal |
Host |
CHO Cells |
Species |
Mouse |
Target |
B7-H1/PD-L1/CD274 |
Gene ID |
60533 |
Isotype |
IgG4SP Kappa |
Size |
100ug, 1mg, 5mg |
Research Area |
Cancer |
CAS Number |
2247114-85-6 |
Product Description |
Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (adebrelimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is kappa. It has a predicted MW of 145.5 kDa. |
Molecular Weight |
145.5 KDa |
Application |
ELISA, Flow Cytometry, Kinetics (BLI), Kinetics (SPR), Functional assay |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
|
Reference 1. Pardoll, D. M. (2012). The blockade of immune checkpoints in cancer immunotherapy. Nature Reviews Cancer, 12(4), 252-264.
2. Topalian, S. L., et al. (2012). Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. New England Journal of Medicine, 366(26), 2443-2454.
3. Iwai, Y., et al. (2002). PD-L1 (B7-H1) and PD-1 (CD279) pathway in cancer immunotherapy. Nature Reviews Immunology, 2(3), 227-238.
|





